Category: Medicine and Supplements - Page 3

Authorized generics are the exact same medication as brand-name drugs, made by the same company, with identical ingredients and effectiveness. They cost less and are just as safe - here’s what you need to know.

Pharmacists use the FDA's Orange Book to legally and safely verify generic drug equivalence. This system ensures generics are bioequivalent to brand-name drugs, saving billions annually while maintaining patient safety through strict scientific standards.

Know what to ask your pharmacist about your prescription meds to avoid dangerous interactions, side effects, and costly mistakes. Get clear answers on dosage, alternatives, and how to stay safe.

Learn how to safely use motion sickness and jet lag medications with expert-backed timing, dosing, and safety tips. Avoid dangerous side effects and get back to enjoying your trip.

The 30-month stay under the Hatch-Waxman Act lets brand drug companies delay generic approval by up to 30 months through patent lawsuits. It’s legal - but it’s costing patients billions. Here’s how it works and why it’s under fire.

Desloratadine and loratadine are both non-sedating antihistamines for allergies. Desloratadine is more potent, lasts longer, and has fewer side effects - but costs more. Learn which one suits your needs.

Cranberry products can dangerously increase warfarin's effects, raising INR levels and risking life-threatening bleeding. Learn why even small amounts pose a threat and what safer alternatives exist.

Learn how to ask your doctor about generic alternatives to save hundreds or even thousands on prescription medications. Discover when generics work just as well, how to talk to your doctor, and what to do if they say no.

Herbal teas may seem harmless, but they can interfere with medications like warfarin, statins, and blood pressure drugs. Learn which teas pose real risks and what to do if you're on prescription meds.

Effective patent life for drugs is often just 10 to 15 years - not 20 - because the patent clock starts at filing, not approval. Learn how regulatory delays, extensions, and secondary patents shape drug pricing and access.